Skip to main content

Opportunities for Accelerating AIDS Vaccine R&D in China

June 15, 2011
This policy brief, produced through a collaboration between IAVI, the Department of Medical Sciences, Technology and Education of China's Ministry of Health and McKinsey and Co., explores how targeted policy reforms focused on strengthening collaboration, sustaining government financing, incentivizing private investment and improving the regulatory and IP environment could accelerate China's participation in AIDS vaccine R&D.

If you have Adobe PDF Viewer, you can browse the publication below.
Otherwise click here to download in English | or Chinese.